Henry Schein, Inc. (NASDAQ:HSIC) Shares Bought by Wedge Capital Management L L P NC

Wedge Capital Management L L P NC lifted its stake in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 5.8% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 471,419 shares of the company's stock after purchasing an additional 26,010 shares during the period. Wedge Capital Management L L P NC owned about 0.36% of Henry Schein worth $35,691,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Xponance Inc. raised its stake in Henry Schein by 2.1% in the third quarter. Xponance Inc. now owns 21,839 shares of the company's stock valued at $1,622,000 after buying an additional 443 shares in the last quarter. Everett Harris & Co. CA raised its stake in Henry Schein by 29.1% in the fourth quarter. Everett Harris & Co. CA now owns 104,677 shares of the company's stock valued at $7,925,000 after buying an additional 23,622 shares in the last quarter. Sprucegrove Investment Management Ltd. raised its stake in Henry Schein by 14.2% in the fourth quarter. Sprucegrove Investment Management Ltd. now owns 220,491 shares of the company's stock valued at $16,693,000 after buying an additional 27,500 shares in the last quarter. Kentucky Retirement Systems Insurance Trust Fund acquired a new stake in Henry Schein in the third quarter valued at $348,000. Finally, Caxton Associates LP raised its stake in Henry Schein by 80.8% in the third quarter. Caxton Associates LP now owns 18,991 shares of the company's stock valued at $1,410,000 after buying an additional 8,486 shares in the last quarter. 96.62% of the stock is currently owned by hedge funds and other institutional investors.

Henry Schein Price Performance

Shares of NASDAQ:HSIC traded up $1.18 during trading on Monday, hitting $72.04. 837,455 shares of the stock were exchanged, compared to its average volume of 1,099,798. The company has a fifty day moving average price of $74.30 and a two-hundred day moving average price of $72.44. The company has a market cap of $9.26 billion, a PE ratio of 22.87, a P/E/G ratio of 1.76 and a beta of 0.87. The company has a current ratio of 1.67, a quick ratio of 1.00 and a debt-to-equity ratio of 0.45. Henry Schein, Inc. has a 12-month low of $60.01 and a 12-month high of $85.39.

Henry Schein (NASDAQ:HSIC - Get Free Report) last issued its quarterly earnings data on Tuesday, February 27th. The company reported $0.66 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.70 by ($0.04). Henry Schein had a return on equity of 14.03% and a net margin of 3.37%. The company had revenue of $3.02 billion for the quarter, compared to analyst estimates of $3 billion. During the same quarter in the prior year, the firm earned $1.21 earnings per share. The company's revenue for the quarter was down 10.5% on a year-over-year basis. On average, analysts forecast that Henry Schein, Inc. will post 5.07 EPS for the current year.

Analyst Ratings Changes

HSIC has been the topic of a number of analyst reports. Evercore ISI raised their price target on Henry Schein from $79.00 to $83.00 and gave the company an "in-line" rating in a research note on Wednesday, February 28th. TheStreet upgraded Henry Schein from a "c+" rating to a "b-" rating in a research report on Monday, February 26th. Jefferies Financial Group lifted their target price on Henry Schein from $74.00 to $81.00 and gave the stock a "hold" rating in a research report on Wednesday, March 6th. SVB Leerink began coverage on Henry Schein in a research report on Monday, February 26th. They set a "market perform" rating and a $78.00 target price on the stock. Finally, Piper Sandler lifted their target price on Henry Schein from $78.00 to $86.00 and gave the stock an "overweight" rating in a research report on Monday, February 26th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat, Henry Schein currently has an average rating of "Hold" and a consensus target price of $81.09.

Insider Buying and Selling

In related news, CEO Bradford C. Connett sold 6,430 shares of Henry Schein stock in a transaction that occurred on Wednesday, March 20th. The stock was sold at an average price of $74.28, for a total transaction of $477,620.40. Following the completion of the transaction, the chief executive officer now directly owns 73,108 shares in the company, valued at approximately $5,430,462.24. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In related news, CEO Bradford C. Connett sold 6,430 shares of Henry Schein stock in a transaction that occurred on Wednesday, March 20th. The stock was sold at an average price of $74.28, for a total transaction of $477,620.40. Following the completion of the transaction, the chief executive officer now directly owns 73,108 shares in the company, valued at approximately $5,430,462.24. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Vice Chairman James P. Breslawski sold 2,907 shares of the business's stock in a transaction on Monday, March 18th. The shares were sold at an average price of $74.37, for a total value of $216,193.59. Following the completion of the transaction, the insider now owns 209,562 shares of the company's stock, valued at $15,585,125.94. The disclosure for this sale can be found here. Insiders own 1.14% of the company's stock.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.